United Kingdom · Question · Written question
UIN 5518
Voluntary Scheme for Branded Medicines Pricing, Access and Growth
Introduced
6 December 2023
Last action
11 December 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
11 December 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 December 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment
Source: Commons
11 December 2023
Answer
Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Healt...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-12-06/5518
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1675844
- uk · wq-1675844 · source updated 11 December 2023